ADIPOQ and obesity disorder: Of these, a reduction in the most abundant anti-inflammatory adipokine, adiponectin, has been documented to play a central role in ASDs and associated disorders, such as atherosclerosis [21], diabetes [22], obesity [23], panic disorders [24], and cardio-metabolic diseases [25].